Clinical Trial Highlights

• IV Exenatide Has the Same Efficacy as Insulin in C ICU Patients, without Inducing Hypoglycemia
• Risk of Mortality Increased with Divergence from Glycemic Target
• Depression Increases Risk for Mortality in People with T2DM
• Long-Term Injection-Free Subcutaneous Delivery of Exenatide via ITCA 650 Improves Compliance and Controls Glycemic Parameters and Weight
• Novel Agent Found to Reduce HbA1C in Type 2 Diabetes
• Intensive Lifestyle Intervention and Metformin are Cost-Effective for Diabetes Prevention
• Intraocular Use of Anti-VEGF Antibody Fragment Improves Vision and Retinal Anatomy in DR